Evidence map›Paper›PMID 35729665›Full record

Observational studyOrphanet journal of rare diseases2022

Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.

S Legoupil, D Bessis, F Picard, S Mallet, J Mazereeuw, A Phan, D Dupin-Deguine, M Kalamarides, Research Group of the French Society of Paediatric Dermatology, C Chiaverini

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

S LegoupilDepartment of Dermatology, CRMRP-Sud, ARCHET 2 Hospital, CHU de Nice, 151 route st Antoine de Ginestière, 06200, Nice, France.
D BessisDepartment of Dermatology, CHU de Montpellier, Montpellier, France.
F PicardDepartment of Dermatology, CHU de Bordeaux, Bordeaux, France.
S MalletDepartment of Dermatology, APHM, Timone Enfant de Marseille, Marseille, France.
J MazereeuwDepartment of Dermatology, CHU de Toulouse, Toulouse, France.
A PhanDepartment of Pediatric Dermatology, Hospices Civils de Lyon, Lyon, France.
D Dupin-DeguineDepartment of ENT, CHU de Toulouse, Toulouse, France.
M KalamaridesDepartment of Neurosurgery, APHP, Pitié-Salpêtrière, Paris, France.
Research Group of the French Society of Paediatric Dermatology
C ChiaveriniDepartment of Dermatology, CRMRP-Sud, ARCHET 2 Hospital, CHU de Nice, 151 route st Antoine de Ginestière, 06200, Nice, France. chiaverini.c@chu-nice.fr.ORCID 0000-0002-6063-5409
Centre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Toulouse · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Montpellier · FRHôpital de la Timone · FRHospices Civils de Lyon · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeurofibromatosis type 2 (NF2) is characterized by bilateral vestibular schwannoma (VS) more often in adults but a severe paediatric form with multiple neurological tumours is also described. In this population, a early diagnosis is important to prevent the onset of neurological complications but is difficult, particularly without a familial history. Cutaneous manifestations, which may precede VS or neurological tumours by several years, may contribute to an early diagnosis, but specific studies are lacking. The objective of this study was to characterize cutaneous manifestations of NF2 in a paediatric population.

resultsThis observational, descriptive and multicentric study was conducted from April 2019 to April 2020 in seven academic French hospitals. We included patients ≤ 18 years old who fulfilled the Manchester diagnostic criteria or had a pathogenic mutation identified in the NF2 gene. All patients underwent a dermatological examination guided by a standardized questionnaire. 21 children were included, of whom 20 had at least one skin tumour (mean number 5 ± 4.6 [range 0-15]), which led to a diagnosis in four cases. In the other 17 cases, the diagnosis of NF2 was based on neurosensory complications (n = 10), family screening (n = 4) or ocular signs (n = 3). Before the NF2 diagnosis, 15 children had at least one "undiagnosed" cutaneous tumour that did not lead to a specific management. Patients' dermatological examination also revealed < 6 non specific café au lait macules (n = 15), hypopigmented macules (n = 12) with more than 3 lesions in 4 cases, and purple reticulated macules of the trunk (n = 4).

conclusionDermatological lesions are frequent and early in children with NF2 but rarely lead to the diagnosis. Cutaneous schwannomas are the most frequent but are often underdiagnosed. Café au lait macules are frequent, but atypical and mostly in small numbers. Multiple hypopigmented macules seem suggestive although inconsistent. The sensitivity of reticulated capillary malformation-like lesions remains to be assessed by further studies.

Indexed as

Nervous System DiseasesNeurilemmomaNeurofibromatosis 1Neurofibromatosis 2Skin NeoplasmsAdolescentCafe-au-Lait SpotsChildCross-Sectional StudiesHumansDermatologyNeurofibromatosis 2Paediatric

Identifiers

PMID35729665
PMCPMC9210598
OpenAlexW4283212987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.